A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer

Clinical trial NCT02543645 · TERMINATED

Trial details

NCT number: NCT02543645
Sponsor: Celldex Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell Kidney Diseases Kidney Neoplasms Urogenital Neoplasms Urologic Diseases Urologic Neoplasms Neoplasms by Histologic Type Neoplasms Clear-cell Metastatic Renal Cell Carcinoma Melanoma Triple Negative Breast Cancer Bladder Cancer

Start date: 2015-10-01
Primary completion: 2017-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.